HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
Recruiting · NCT06824155 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HEAT Trial (HER2 Antibody Therapy With Lutetium-177) | Advanced Solid Tumors; HER2 Gene Mutation | Recruiting | Early phase 1 | 2026-09-24 | NCT06824155 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Radiopharm Theranostics, Ltd | 7 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| GenesisCare Murdoch | Murdoch | Australia | 3 |
| Macquarie University Hospital | Macquarie Park | Australia | 10 |
| Nepean Hospital | Kingswood | Australia | 26 |
| St Vincents Hospital, Melbourne | Fitzroy | Australia | 1 |
| Wollongong Hospital | Wollongong | Australia | 29 |